Moderna Inc
NASDAQ: MRNA
$43.47
+$0.72 (+1.7%)
Closing Price on November 12, 2024
MRNA Stock Chart and Intraday Price
MRNA Stock Data
| Asset Type | Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| Address | 200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 36,319.86M USD |
| Shares Outstanding | 382,073,000 |
MRNA Articles
Investors have been on a roller coaster ride for the past four years and the stock market may be heading into another big loop higher. Federal Reserve chairman Jay Powell gave his strongest...
Published:
Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big expectations for Vir Biotechnology.
Published:
Invesco QQQ Trust (NASDAQ: QQQ) is an ETF that tracks the performance of the 100 largest companies listed on the Nasdaq. While this is mainly made up of technology companies, it holds the stocks in...
Published:
With the pandemic largely in the rear-view mirror, COVID-19 vaccine winner Novavax has seen shares fall. Yet, analysts have high hopes for the stock.
Published:
Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital...
Published:
Analysts have been cutting ratings and price targets recently, but here are four stocks that defying the downward pressure.
Published:
2018 was one of the last full years we would feel normal as a world for a long time. We had no idea what was hurling around the corner. That year, Drake led the charts with “God’s Plan” and...
Published:
U.S. stocks are adding to Wednesday's comeback with solid gains after about half an hour of trading Thursday morning. Here are winners and losers.
Published:
Pfizer stock has tumbled due to shrinking vaccine sales and the potential for a social and consumer backlash. Moderna stock has also been pounded.
Published:
Monday's top analyst upgrades and downgrades included Amazon.com, Amgen, Apple, BioCryst Pharmaceuticals, Block, Coinbase Global, Datadog, Fortinet, Gilead Sciences, Intercontinental Exchange,...
Published:
Friday's top analyst upgrades and downgrades included DXC Technology, Etsy, Extreme Networks, Moderna, PagSeguro Digital, Qualcomm, Roku, Ross Stores, Royal Caribbean Cruises, Southwest Airlines,...
Published:
Monday's top analyst upgrades and downgrades included Academy Sports and Outdoors, Accenture, Clorox, Fiserv, Moderna, Planet Fitness, Sarepta Therapeutics, Tesla, Under Armour, Ventas, Viatris,...
Published:
Tuesday's top analyst upgrades and downgrades included Agilon Health, Boston Scientific, General Motors, JPMorgan Chase, Match, Moderna, Okta, Palo Alto Networks, Snap, Uber Technologies and Wells...
Published:
Wednesday morning's report on the consumer price index likely will set the direction for stock traders. But there are some outliers.
Published:
Tuesday's top analyst upgrades and downgrades included Ally Financial, Amgen, Baidu, Bilibili, Bill.com, Coinbase Global, Eli Lilly, GE Healthcare Technologies, JPMorgan Chase, Merck, Moderna,...
Published: